{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:15:44Z","timestamp":1790489744417,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Pharos University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hypoxia is a prevalent hallmark of many malignant neoplasms. The aim was to assess the serum hypoxia biomarkers HIF-1\u03b1, VEGF, osteopontin, erythropoietin, caveolin-1, GLUT-1, and LDH pre- and post-radiotherapy in patients with brain tumors. The study was conducted on 120 subjects were divided into two groups: group I: 40 healthy volunteers as control group. Group II: 80 brain tumor patients were subdivided into glioblastoma subgroup: 40 glioblastoma patients, meningioma subgroup: 40 malignant meningioma patients. Two venous blood samples were collected from every patient prior to and following RT and one sample from controls. Biomarkers were assayed by ELISA. In glioblastoma subgroup, HIF-1\u03b1, VEGF, and LDH were significantly increased after RT. On the contrary, these biomarkers were significantly decreased after RT in malignant meningioma subgroup. Osteopontin was significantly increased after RT in both subgroups. Regarding erythropoietin, it was significantly decreased in both subgroups when compared to before RT. Caveolin-1 showed a significant increase in glioblastoma subgroup after RT comparing to before RT. GLUT-1 was significantly increased after RT in both subgroups comparing to before RT. Association of significant elevation of hypoxia biomarkers either pre- or post-RT with aggressive tumor such as glioblastoma indicates that, they are markers of malignancy and may have a role in tumor development and progression.\n<\/jats:p>","DOI":"10.1007\/s12031-022-02065-z","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T09:03:27Z","timestamp":1663578207000},"page":"2303-2312","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Assessment of Serum Hypoxia Biomarkers Pre- and Post-radiotherapy in Patients with Brain Tumors"],"prefix":"10.1007","volume":"72","author":[{"given":"Sanaa A.","family":"El-Benhawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola A.","family":"Sakr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enayat I.","family":"Fahmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raed A.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed S.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esraa M.","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif M.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehal","family":"Abu-Samra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif","family":"Elzawawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,19]]},"reference":[{"key":"2065_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.613114","volume":"11","author":"R Abou Khouzam","year":"2021","unstructured":"Abou Khouzam R et al (2021) Tumor hypoxia regulates immune escape\/invasion: influence on angiogenesis and potential impact of hypoxic biomarkers on cancer therapies. Front Immunol 11:613114. https:\/\/doi.org\/10.3389\/fimmu.2020.613114","journal-title":"Front Immunol"},{"issue":"2","key":"2065_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10014-010-0012-2","volume":"28","author":"V Barresi","year":"2011","unstructured":"Barresi V (2011) Angiogenesis in meningiomas. Brain Tumor Pathol 28(2):99\u2013106","journal-title":"Brain Tumor Pathol"},{"issue":"1","key":"2065_CR3","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1021\/acs.jproteome.9b00521","volume":"19","author":"L Bender","year":"2020","unstructured":"Bender L et al (2020) Metabolomic profile of aggressive meningiomas by using high-resolution magic angle spinning nuclear magnetic resonance. J Proteome Res 19(1):292\u2013299","journal-title":"J Proteome Res"},{"issue":"4","key":"2065_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2174\/1566524018666180926163218","volume":"18","author":"J Castillo Bennett","year":"2018","unstructured":"Castillo Bennett J, Silva P, Martinez S, Torres VA, Quest AFG (2018) Hypoxia-induced caveolin-1 expression promotes migration and invasion of tumor cells. Curr Mol Med 18(4):199\u2013206. https:\/\/doi.org\/10.2174\/1566524018666180926163218","journal-title":"Curr Mol Med"},{"key":"2065_CR5","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.3892\/ol.2019.9929","volume":"17","author":"W Chen","year":"2019","unstructured":"Chen W et al (2019) Clinical implications of hypoxia-inducible factor-1\u03b1 and caveolin-1 overexpression in isocitrate dehydrogenase-wild type glioblastoma multiforme. Oncol Lett 17:2867\u20132873. https:\/\/doi.org\/10.3892\/ol.2019.9929","journal-title":"Oncol Lett"},{"key":"2065_CR6","doi-asserted-by":"publisher","first-page":"10653","DOI":"10.1590\/1414-431X2020e10653.PMID:34287575;PMCID:PMC8289350","volume":"10","author":"W Chen","year":"2021","unstructured":"Chen W et al (2021) Caveolin-1 promotes tumor cell proliferation and vasculogenic mimicry formation in human glioma. Braz J Med Biol Res 10:10653. https:\/\/doi.org\/10.1590\/1414-431X2020e10653.PMID:34287575;PMCID:PMC8289350","journal-title":"Braz J Med Biol Res"},{"issue":"4","key":"2065_CR7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.4103\/0377-4929.125286","volume":"56","author":"P Dharmalingam","year":"2013","unstructured":"Dharmalingam P, Kumar VR, Verma S (2013) Vascular endothelial growth factor expression and angiogenesis in various grades and subtypes of meningioma. Indian J Pathol Microbiol 56(4):349\u2013354","journal-title":"Indian J Pathol Microbiol"},{"issue":"16","key":"2065_CR8","doi-asserted-by":"publisher","first-page":"8942","DOI":"10.3390\/ijms22168942","volume":"22","author":"G Frosina","year":"2021","unstructured":"Frosina G (2021) Radiotherapy of high-grade gliomas: first half of 2021 update with special reference to radiosensitization studies. Int J Mol Sci 22(16):8942. https:\/\/doi.org\/10.3390\/ijms22168942","journal-title":"Int J Mol Sci"},{"key":"2065_CR9","doi-asserted-by":"publisher","unstructured":"Henry A et al (2016) New role of osteopontin in DNA repair and impact on human glioblastoma radiosensitivity. Oncotarget 7(39):63708\u201363721. https:\/\/doi.org\/10.18632\/oncotarget.11483","DOI":"10.18632\/oncotarget.11483"},{"issue":"6","key":"2065_CR10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.clon.2007.03.001","volume":"19","author":"IJ Hoogsteen","year":"2007","unstructured":"Hoogsteen IJ, Marres HA, van der Kogel AJ, Kaanders JH (2007) The hypoxic tumour microenvironment, patient selection and hypoxia-modifying treatments. Clin Oncol 19(6):385\u2013396","journal-title":"Clin Oncol"},{"key":"2065_CR11","doi-asserted-by":"publisher","unstructured":"Hompland T, Fjeldbo CS, Lyng H (2021) Tumor hypoxia as a barrier in cancer therapy: why levels matter. Cancers 13(3):499. https:\/\/doi.org\/10.3390\/cancers13030499","DOI":"10.3390\/cancers13030499"},{"key":"2065_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1201\/b13224-16","volume":"4","author":"MR Horsman","year":"2009","unstructured":"Horsman MR, Wouters BG, Joiner MC, Overgaard J (2009) The oxygen effect and fractionated radiotherapy. Basic Clin Radiobiol 4:207\u2013216","journal-title":"Basic Clin Radiobiol"},{"issue":"1","key":"2065_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.5732\/cjc.013.10207","volume":"33","author":"AF Hottinger","year":"2014","unstructured":"Hottinger AF, Stupp R, Homicsko K (2014) Standards of care and novel approaches in the management of glioblastoma multiforme. Chin J Cancer Res 33(1):32\u201339","journal-title":"Chin J Cancer Res"},{"issue":"1","key":"2065_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02482169","volume":"21","author":"N Irie","year":"2004","unstructured":"Irie N, Matsuo T, Nagata I (2004) Protocol of radiotherapy for glioblastoma according to the expression of HIF-1. Brain Tumor Pathol 21(1):1\u20136","journal-title":"Brain Tumor Pathol"},{"key":"2065_CR15","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3389\/fonc.2018.00419","volume":"8","author":"KK Jain","year":"2018","unstructured":"Jain KK (2018) A critical overview of targeted therapies for glioblastoma. Front Oncol 8:419. https:\/\/doi.org\/10.3389\/fonc.2018.00419","journal-title":"Front Oncol"},{"issue":"1","key":"2065_CR16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1227\/NEU.0b013e3182567886","volume":"71","author":"R Jensen","year":"2012","unstructured":"Jensen R, Lee J (2012) Predicting outcomes of patients with intracranial meningiomas using molecular markers of hypoxia, vascularity, and proliferation. Neurosurg 71(1):146\u2013156","journal-title":"Neurosurg"},{"issue":"9","key":"2065_CR17","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jocn.2007.07.080","volume":"15","author":"MY Kaynar","year":"2008","unstructured":"Kaynar MY et al (2008) Expression of hypoxia inducible factor-1alpha in tumors of patients with glioblastoma multiforme and transitional meningioma. J Clin Neurosci 15(9):1036\u20131042","journal-title":"J Clin Neurosci"},{"key":"2065_CR18","doi-asserted-by":"crossref","unstructured":"Ketteler J,&nbsp;Klein D (2018) Caveolin-1, cancer and therapy resistance. Int J Cancer 143(9):2092\u20132104","DOI":"10.1002\/ijc.31369"},{"key":"2065_CR19","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1186\/s12889-020-09838-4","volume":"20","author":"Z Khazaei","year":"2020","unstructured":"Khazaei Z et al (2020) The association between incidence and mortality of brain cancer and human development index (HDI): an ecological study. BMC Public Health 20:1696. https:\/\/doi.org\/10.1186\/s12889-020-09838-4","journal-title":"BMC Public Health"},{"issue":"16","key":"2065_CR20","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.4161\/cc.7.16.6442","volume":"7","author":"P Knizetova","year":"2008","unstructured":"Knizetova P et al (2008) Autocrine regulation of glioblastoma cell cycle progression, viability and radioresistance through the VEGF-VEGFR2 (KDR) interplay. Cell Cycle 7(16):2553\u20132561","journal-title":"Cell Cycle"},{"issue":"8","key":"2065_CR21","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1021\/acs.jproteome.0c00415","volume":"19","author":"T Kohata","year":"2020","unstructured":"Kohata T et al (2020) Laminin subunit alpha-4 and osteopontin are glioblastoma-selective secreted proteins that are increased in the cerebrospinal fluid of glioblastoma patients. J Proteome Res 19(8):3542\u20133553","journal-title":"J Proteome Res"},{"key":"2065_CR22","doi-asserted-by":"publisher","unstructured":"Kong FM et al (2017) Effect of midtreatment PET\/CT-adapted radiation therapy with concurrent chemotherapy in patients with locally advanced non-small-cell lung cancer: a phase 2 clinical trial. JAMA Oncol 3(10):1358\u20131365.\u00a0https:\/\/doi.org\/10.1001\/jamaoncol.2017.0982","DOI":"10.1001\/jamaoncol.2017.0982"},{"key":"2065_CR23","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3389\/fonc.2017.00182","volume":"7","author":"R Krcek","year":"2017","unstructured":"Krcek R et al (2017) Vascular endothelial growth factor, irradiation, and axitinib have diverse effects on motility and proliferation of glioblastoma multiforme cells. Front Oncol 7:182","journal-title":"Front Oncol"},{"key":"2065_CR24","doi-asserted-by":"publisher","first-page":"841","DOI":"10.2147\/OTT.S242263","volume":"13","author":"G Lazzari","year":"2020","unstructured":"Lazzari G, Silvano G (2020) From anemia to erythropoietin resistance in head and neck squamous cell carcinoma treatment: a carousel driven by hypoxia. OncoTargets Ther 13:841","journal-title":"OncoTargets Ther"},{"issue":"1","key":"2065_CR25","first-page":"59","volume":"9","author":"QT Le","year":"2003","unstructured":"Le QT et al (2003) Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas. Clin Cancer Res 9(1):59\u201367","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2065_CR26","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/ars.2013.5759","volume":"21","author":"CT Lee","year":"2014","unstructured":"Lee CT, Boss MK, Dewhirst MW (2014) Imaging tumor hypoxia to advance radiation oncology. Antioxid Redox Signal 21(2):313\u2013337. https:\/\/doi.org\/10.1089\/ars.2013.5759","journal-title":"Antioxid Redox Signal"},{"key":"2065_CR27","doi-asserted-by":"publisher","unstructured":"Lee CW et al (2018) Extracts of Artocarpus communis induce mitochondria-associated apoptosis via pro-oxidative activity in human glioblastoma cells. Front Pharmacol 9.\u00a0https:\/\/doi.org\/10.2147\/HP.S93413","DOI":"10.2147\/HP.S93413"},{"issue":"2","key":"2065_CR28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10555-007-9066-y","volume":"26","author":"D Liao","year":"2007","unstructured":"Liao D, Johnson RS (2007) Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev 26(2):281\u2013290","journal-title":"Cancer Metastasis Rev"},{"key":"2065_CR29","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3389\/fonc.2018.00249","volume":"8","author":"A Lo Dico","year":"2018","unstructured":"Lo Dico A, Martelli C, Diceglie C, Lucignani G, Ottobrini L (2018) Hypoxia-inducible factor-1\u03b1 activity as a switch for glioblastoma responsiveness to temozolomide. Front Oncol 8:249","journal-title":"Front Oncol"},{"issue":"11","key":"2065_CR30","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/neuonc\/nos262","volume":"14","author":"DY Lu","year":"2012","unstructured":"Lu DY et al (2012) Osteopontin increases heme oxygenase-1 expression and subsequently induces cell migration and invasion in glioma cells. Neuro-Oncol 14(11):1367\u20131378","journal-title":"Neuro-Oncol"},{"key":"2065_CR31","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12576-020-00773-y","volume":"70","author":"AA Mamun","year":"2020","unstructured":"Mamun AA, Hayashi H, Yamamura A et al (2020) Hypoxia induces the translocation of glucose transporter 1 to the plasma membrane in vascular endothelial cells. J Physiol Sci 70:44. https:\/\/doi.org\/10.1186\/s12576-020-00773-y","journal-title":"J Physiol Sci"},{"issue":"24","key":"2065_CR32","doi-asserted-by":"publisher","first-page":"7242","DOI":"10.1158\/0008-5472.CAN-16-1031","volume":"76","author":"X Mao","year":"2016","unstructured":"Mao X et al (2016) Mechanisms through which hypoxia-induced caveolin-1 drives tumorigenesis and metastasis in hepatocellular carcinoma. Cancer Res 76(24):7242\u20137253","journal-title":"Cancer Res"},{"key":"2065_CR33","doi-asserted-by":"publisher","unstructured":"Muz B, Puente de la P, Azab F, Azab AK (2015) The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy Hypoxia 11(3):83\u201392.\u00a0https:\/\/doi.org\/10.2147\/HP.S93413","DOI":"10.2147\/HP.S93413"},{"issue":"20","key":"2065_CR34","doi-asserted-by":"publisher","first-page":"5585","DOI":"10.1158\/1078-0432.CCR-12-0858","volume":"18","author":"TW Meijer","year":"2012","unstructured":"Meijer TW, Kaanders JH, Span PN, Bussink J (2012) Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy. Clin Cancer Res 18(20):5585\u20135594","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2065_CR35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/cells6040045","volume":"6","author":"AR Monteiro","year":"2017","unstructured":"Monteiro AR, Hill R, Pilkington GJ, Madureira PA (2017) The role of hypoxia in glioblastoma invasion. Cells 6(4):45","journal-title":"Cells"},{"issue":"3","key":"2065_CR36","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1080\/0284186X.2016.1259659","volume":"56","author":"P Mozes","year":"2017","unstructured":"Mozes P et al (2017) Volumetric response of intracranial meningioma after photon or particle irradiation. Acta Oncol 56(3):431\u2013437","journal-title":"Acta Oncol"},{"issue":"2","key":"2065_CR37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1023\/A:1006333005563","volume":"45","author":"RD Oehring","year":"1999","unstructured":"Oehring RD et al (1999) Vascular endothelial growth factor (VEGF) in astrocytic gliomas\u2013a prognostic factor? J Neurooncol 45(2):117\u2013125","journal-title":"J Neurooncol"},{"issue":"9","key":"2065_CR38","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3109\/00207454.2013.789874","volume":"123","author":"J Reszec","year":"2013","unstructured":"Reszec J, Rutkowski R, Chyczewski L (2013) The expression of hypoxia-inducible factor-1 in primary brain tumors. Int J Neurosci 123(9):657\u2013662","journal-title":"Int J Neurosci"},{"key":"2065_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11060-010-0290-x","volume":"102","author":"G Reynes","year":"2011","unstructured":"Reynes G et al (2011) Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma. J Neurooncol 102:35\u201341. https:\/\/doi.org\/10.1007\/s11060-010-0290-x","journal-title":"J Neurooncol"},{"key":"2065_CR40","first-page":"18541","volume":"8","author":"S Roy","year":"2018","unstructured":"Roy S, Bandyopadhyay S (2018) Brain tumor classification and performance analysis. IJESC 8:18541\u201318545","journal-title":"IJESC"},{"issue":"11","key":"2065_CR41","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1182\/blood.V76.11.2354.2354","volume":"76","author":"L Schapira","year":"1990","unstructured":"Schapira L, Antin J, Ransil B, Antman K, Eder J, McGarigle C et al (1990) Serum erythropoietin levels in patients receiving intensive chemotherapy and radiotherapy. Blood 76(11):2354\u20132359","journal-title":"Blood"},{"key":"2065_CR42","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/978-3-030-12734-3_5","volume":"1136","author":"L Schito","year":"2019","unstructured":"Schito L (2019) Hypoxia-dependent angiogenesis and lymphangiogenesis in cancer. Adv Exp Med Biol 1136:71\u201385. https:\/\/doi.org\/10.1007\/978-3-030-12734-3_5","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"2065_CR43","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ejso.2009.07.010","volume":"36","author":"MU Schuhmann","year":"2010","unstructured":"Schuhmann MU et al (2010) Peptide screening of cerebrospinal fluid in patients with glioblastoma multiforme. Eur J Surg Oncol 36(2):201\u2013207","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"2065_CR44","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.2217\/fon.10.123","volume":"6","author":"JP Sheehan","year":"2010","unstructured":"Sheehan JP et al (2010) Improving the radiosensitivity of radioresistant and hypoxic glioblastoma. Future Oncol 6(10):1591\u20131601","journal-title":"Future Oncol"},{"issue":"2","key":"2065_CR45","first-page":"2354","volume":"8","author":"M \u015aniegocki","year":"2021","unstructured":"\u015aniegocki M, Siedlecki Z, Nowak K, Grzyb S, Shaik FA (2021) Angiogenesis in brain tumors: gliomas and meningiomas-a review. Eur J Mol Clin Med 8(2):2354\u20132359","journal-title":"Eur J Mol Clin Med"},{"key":"2065_CR46","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1158\/1055-9965.EPI-09-1077","volume":"19","author":"P Sreekanthreddy","year":"2010","unstructured":"Sreekanthreddy P et al (2010) Identification of potential serum biomarkers of glioblastoma: serum osteopontin levels correlate with poor prognosis. Cancer Epidemiol Biomarkers Prev 19:1409\u20131422","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2065_CR47","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.3389\/fphys.2019.01534","volume":"10","author":"S Suresh","year":"2020","unstructured":"Suresh S, Rajvanshi PK, Noguchi CT (2020) The many facets of erythropoietin physiologic and metabolic response. Front Physiol 10:1534. https:\/\/doi.org\/10.3389\/fphys.2019.01534","journal-title":"Front Physiol"},{"issue":"8","key":"2065_CR48","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.3390\/cells10082140","volume":"10","author":"AS Tsiftsoglou","year":"2021","unstructured":"Tsiftsoglou AS (2021) Erythropoietin (EPO) as a key regulator of erythropoiesis, bone remodeling and endothelial transdifferentiation of multipotent mesenchymal stem cells (MSCs): implications in regenerative medicine. Cells 10(8):2140. https:\/\/doi.org\/10.3390\/cells10082140","journal-title":"Cells"},{"issue":"1","key":"2065_CR49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bpa.12299","volume":"26","author":"CJ Valvona","year":"2016","unstructured":"Valvona CJ, Fillmore HL, Nunn PB, Pilkington GJ (2016) The regulation and function of lactate dehydrogenase a: therapeutic potential in brain tumor. Brain Pathol 26(1):3\u201317. https:\/\/doi.org\/10.1111\/bpa.12299","journal-title":"Brain Pathol"},{"key":"2065_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpc.2019.108563","volume":"225","author":"J Xie","year":"2019","unstructured":"Xie J et al (2019) Expression of lactate dehydrogenase is induced during hypoxia via HIF-1 in the mud crab Scylla paramamosain. Comp Biochem Physiol C Toxicol Pharmacol 225:108563. https:\/\/doi.org\/10.1016\/j.cbpc.2019.108563","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"issue":"8","key":"2065_CR51","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/neuonc\/noq006","volume":"12","author":"W Yan","year":"2010","unstructured":"Yan W et al (2010) Expression pattern of osteopontin splice variants and its functions on cell apoptosis and invasion in glioma cells. Neuro-Oncol 12(8):765\u2013775","journal-title":"Neuro-Oncol"},{"issue":"2","key":"2065_CR52","doi-asserted-by":"publisher","first-page":"17","DOI":"10.14218\/ERHM.2015.00004","volume":"1","author":"M Zhang","year":"2016","unstructured":"Zhang M, Zhou Z, Zhou Z, Garrison J (2016) Targeting tumor hypoxia in radiotherapy: a brief review of historical background and recent progress. Explor Res Hypothesis Med 1(2):17\u201328. https:\/\/doi.org\/10.14218\/ERHM.2015.00004","journal-title":"Explor Res Hypothesis Med"},{"issue":"5","key":"2065_CR53","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00280-016-3007-9","volume":"77","author":"F Zhao","year":"2016","unstructured":"Zhao F, Ming J, Zhou Y, Fan L (2016) Inhibition of Glut1 by WZB117 sensitizes radioresistant breast cancer cells to irradiation. Cancer Chemother Pharmacol 77(5):963\u2013972. https:\/\/doi.org\/10.1007\/s00280-016-3007-9","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-022-02065-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-022-02065-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-022-02065-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T11:03:33Z","timestamp":1670670213000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-022-02065-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,19]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["2065"],"URL":"https:\/\/doi.org\/10.1007\/s12031-022-02065-z","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,19]]},"assertion":[{"value":"13 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}